Does tumour necrosis factor alpha influence insulin sensitivity in skeletal muscle?
Byrne
C D
CD
Endocrinology & Metabolism, Wellcome Clinical Research Facility, University of Southampton, School of Medicine, Level D, South Academic Block (MP811), Southampton General Hospital, Tremona Road, Southampton SO16 6YD, UK.
D000818:Animals; D003924:Diabetes Mellitus, Type 2 / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D007328:Insulin / Q000502:physiology*; D007333:Insulin Resistance / Q000502:physiology; D020928:Mitogen-Activated Protein Kinases / Q000502:physiology; D018482:Muscle, Skeletal / Q000502:physiology*; D009765:Obesity / Q000150:complications / Q000503:physiopathology; D019869:Phosphatidylinositol 3-Kinases / Q000502:physiology; D010766:Phosphorylation; D051381:Rats; D014409:Tumor Necrosis Factor-alpha / Q000502:physiology*; D015854:Up-Regulation
D007328:Insulin; D014409:Tumor Necrosis Factor-alpha; D019869:Phosphatidylinositol 3-Kinases; D020928:Mitogen-Activated Protein Kinases